diclofenac and thromboxane a2

diclofenac has been researched along with thromboxane a2 in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (20.00)	18.7374
1990's	3 (30.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Korttila, K; Valanne, J; Ylikorkala, O	1
Inada, Y; Kato, K; Nishikawa, K; Shibouta, Y; Terashita, ZI	1
Bauersachs, J; Busse, R; Hecker, M	1
Heller, A; Koch, T; Neuhof, H; Patt, B; Schmeck, J; van Ackern, K	1
Janzen, R; Koch, T; Münter, K; Neuhof, H; Schmeck, J	1
Gröschler, A; Heller, A; Koch, T; Neuhof, H; Recker, A; Schmeck, J; Urbaschek, R	1
Gluth, H; Koch, T; Konrad, C; Krafft, P; Schmeck, J; Schöffel, S; Wendel-Wellner, M	1
Bishop-Bailey, D; Mitchell, JA; Vojnovic, I; Warner, TD	1
Marwali, MR; Mehta, JL	1
Dahlén, SE; Kumlin, M; Låstbom, L; Ryrfeldt, A; Selg, E	1

Reviews

1 review(s) available for diclofenac and thromboxane a2

Article	Year
COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies. Thrombosis and haemostasis, 2006, Volume: 96, Issue:4 Topics: Animals; Blood Platelets; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Labeling; Endothelium, Vascular; Epoprostenol; Humans; Lactones; Platelet Aggregation; Product Surveillance, Postmarketing; Pyrazoles; Randomized Controlled Trials as Topic; Risk Assessment; Sulfonamides; Sulfones; Thromboxane A2	2006

Article

Year

COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies.

Thrombosis and haemostasis, 2006, Volume: 96, Issue:4

Topics: Animals; Blood Platelets; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Labeling; Endothelium, Vascular; Epoprostenol; Humans; Lactones; Platelet Aggregation; Product Surveillance, Postmarketing; Pyrazoles; Randomized Controlled Trials as Topic; Risk Assessment; Sulfonamides; Sulfones; Thromboxane A2

2006

Trials

1 trial(s) available for diclofenac and thromboxane a2

Article	Year
Intravenous diclofenac sodium decreases prostaglandin synthesis and postoperative symptoms after general anaesthesia in outpatients undergoing dental surgery. Acta anaesthesiologica Scandinavica, 1987, Volume: 31, Issue:8 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, General; Diclofenac; Double-Blind Method; Epoprostenol; Female; Humans; Injections, Intravenous; Isoflurane; Male; Oral Hemorrhage; Pain, Postoperative; Random Allocation; Thromboxane A2	1987

Article

Year

Intravenous diclofenac sodium decreases prostaglandin synthesis and postoperative symptoms after general anaesthesia in outpatients undergoing dental surgery.

Acta anaesthesiologica Scandinavica, 1987, Volume: 31, Issue:8

Topics: 6-Ketoprostaglandin F1 alpha; Adult; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, General; Diclofenac; Double-Blind Method; Epoprostenol; Female; Humans; Injections, Intravenous; Isoflurane; Male; Oral Hemorrhage; Pain, Postoperative; Random Allocation; Thromboxane A2

1987

Other Studies

8 other study(ies) available for diclofenac and thromboxane a2

Article	Year
Renal effects of pinane-thromboxane A2 and indomethacin in saline volume-expanded spontaneously hypertensive rats. European journal of pharmacology, 1982, Nov-05, Volume: 85, Issue:1 Topics: Animals; Bicyclic Monoterpenes; Blood Pressure; Diclofenac; Hypertension; Indomethacin; Kidney; Male; Potassium; Prostaglandins; Rats; Rats, Inbred Strains; Sodium; Thromboxane A2; Thromboxanes	1982
Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. British journal of pharmacology, 1994, Volume: 113, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Arginine; Biological Factors; Bradykinin; Calcium Channel Blockers; Capillaries; Coronary Vessels; Cytochrome P-450 Enzyme System; Diclofenac; Epoprostenol; Female; In Vitro Techniques; Male; Nitric Oxide; Nitroarginine; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Quinacrine; Rats; Rats, Wistar; Thromboxane A2; Vasoconstrictor Agents; Vasodilation	1994
The role of endothelin-1 as a mediator of the pressure response after air embolism in blood perfused lungs. Intensive care medicine, 1998, Volume: 24, Issue:6 Topics: Analysis of Variance; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Embolism, Air; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Hypertension, Pulmonary; In Vitro Techniques; Oligopeptides; Perfusion; Phenylpropionates; Piperidines; Pulmonary Artery; Pulmonary Embolism; Pyrimidines; Rabbits; Radioimmunoassay; Thromboxane A2; Time Factors; Vascular Resistance	1998
Endothelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte-mediated lung injury. Critical care medicine, 1998, Volume: 26, Issue:11 Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Female; Granulocytes; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Perfusion; Phenylpropionates; Prospective Studies; Pulmonary Artery; Pyrimidines; Rabbits; Random Allocation; Respiratory Distress Syndrome; Thromboxane A2; Thromboxane B2; Vascular Resistance	1998
Impact of endothelin-1 in endotoxin-induced pulmonary vascular reactions. Critical care medicine, 2000, Volume: 28, Issue:8 Topics: Animals; Cyclooxygenase Inhibitors; Diclofenac; Endothelin Receptor Antagonists; Endothelin-1; Female; Lipopolysaccharides; Male; Phenylpropionates; Prospective Studies; Pulmonary Artery; Pulmonary Wedge Pressure; Pyrimidines; Rabbits; Thromboxane A2	2000
Interaction of acetylcholine and endothelin-1 in the modulation of pulmonary arterial pressure. Critical care medicine, 2000, Volume: 28, Issue:12 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Endothelin Receptor Antagonists; Endothelin-1; Female; Hypertension, Pulmonary; In Vitro Techniques; Male; Peptides, Cyclic; Pulmonary Circulation; Pulmonary Wedge Pressure; Rabbits; Thromboxane A2; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilation	2000
Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:3 Topics: Aspirin; Blood Platelets; Blood Proteins; Calcimycin; Calcium; Celecoxib; Cell Line; Cerebrospinal Fluid Proteins; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Humans; Indomethacin; Ionophores; Lactones; Meloxicam; Naproxen; Organ Specificity; Organic Chemicals; Protein Binding; Pyrazoles; Sodium Salicylate; Sulfonamides; Sulfones; Synovial Fluid; Thiazines; Thiazoles; Thromboxane A2	2006
Effects of selective and non-selective COX inhibitors on antigen-induced release of prostanoid mediators and bronchoconstriction in the isolated perfused and ventilated guinea pig lung. Prostaglandins, leukotrienes, and essential fatty acids, 2008, Volume: 78, Issue:2 Topics: Animals; Bronchoconstriction; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diclofenac; Flurbiprofen; Guinea Pigs; Humans; Leukotrienes; Lung; Male; Ovalbumin; Piperazines; Prostaglandins; Pyrazoles; Sulfonamides; Thiazoles; Thromboxane A2; Thromboxane B2	2008